Bone morphogenetic proteins

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

This chapter describes the role of bone matrix as a repository of growth, and morphogenetic factors, including bone morphogenetic proteins. Demineralized bone matrix is the initial starting biomaterial for isolation, purification and molecular cloning, and expression of bone morphogenetic proteins (BMPs). There are 15 members of the BMP family in humans, and they have wide-ranging actions on tissues beyond bone. The action of BMPs is mediated by receptors for BMPs. The type I and II BMP receptors bind BMPs, and the activated receptors phosphorylate intracellular substrates, called Smads. The term Smad is a fusion of two genes Sma in worms, and a human homolog of a Drosophila gene Mad (mothers against decapentaplegic). BMP receptors phosphorylate Smads 1, 5, and 8 in cytoplasm. Upon phosphorylation they enter the nucleus in partnership with a common partner Smad 4, and turn on the gene expression. The bioavailability of BMPs for receptor binding is influenced by BMP-binding proteins such as noggin and chordin, and interactions with extracellular matrix components, such as type W collagen and heparan sulfate. BMPs may have potential clinical utility in fracture healing, spine fusion, reconstructive surgery, oral surgery, and plastic surgery.

Original languageEnglish (US)
Title of host publicationThe Cytokine Handbook
PublisherElsevier Inc.
Pages1179-1185
Number of pages7
ISBN (Print)9780080518794, 9780126896633
DOIs
StatePublished - Jul 7 2003

Fingerprint

Bone Morphogenetic Proteins
Bone Morphogenetic Protein Receptors
Bone Matrix
Protein Binding
Smad4 Protein
Bone Morphogenetic Protein 15
Reconstructive Surgical Procedures
Type I Bone Morphogenetic Protein Receptors
Type II Bone Morphogenetic Protein Receptors
Fracture Healing
Heparitin Sulfate
Oral Surgery
Gene Fusion
Molecular Cloning
Biocompatible Materials
Plastic Surgery
Biological Availability
Drosophila
Extracellular Matrix
Intercellular Signaling Peptides and Proteins

ASJC Scopus subject areas

  • Medicine(all)
  • Immunology and Microbiology(all)

Cite this

Reddi, A. H. (2003). Bone morphogenetic proteins. In The Cytokine Handbook (pp. 1179-1185). Elsevier Inc.. https://doi.org/10.1016/B978-012689663-3/50055-7

Bone morphogenetic proteins. / Reddi, A Hari.

The Cytokine Handbook. Elsevier Inc., 2003. p. 1179-1185.

Research output: Chapter in Book/Report/Conference proceedingChapter

Reddi, AH 2003, Bone morphogenetic proteins. in The Cytokine Handbook. Elsevier Inc., pp. 1179-1185. https://doi.org/10.1016/B978-012689663-3/50055-7
Reddi AH. Bone morphogenetic proteins. In The Cytokine Handbook. Elsevier Inc. 2003. p. 1179-1185 https://doi.org/10.1016/B978-012689663-3/50055-7
Reddi, A Hari. / Bone morphogenetic proteins. The Cytokine Handbook. Elsevier Inc., 2003. pp. 1179-1185
@inbook{0906b11c1ab94130883c8a4a6662398b,
title = "Bone morphogenetic proteins",
abstract = "This chapter describes the role of bone matrix as a repository of growth, and morphogenetic factors, including bone morphogenetic proteins. Demineralized bone matrix is the initial starting biomaterial for isolation, purification and molecular cloning, and expression of bone morphogenetic proteins (BMPs). There are 15 members of the BMP family in humans, and they have wide-ranging actions on tissues beyond bone. The action of BMPs is mediated by receptors for BMPs. The type I and II BMP receptors bind BMPs, and the activated receptors phosphorylate intracellular substrates, called Smads. The term Smad is a fusion of two genes Sma in worms, and a human homolog of a Drosophila gene Mad (mothers against decapentaplegic). BMP receptors phosphorylate Smads 1, 5, and 8 in cytoplasm. Upon phosphorylation they enter the nucleus in partnership with a common partner Smad 4, and turn on the gene expression. The bioavailability of BMPs for receptor binding is influenced by BMP-binding proteins such as noggin and chordin, and interactions with extracellular matrix components, such as type W collagen and heparan sulfate. BMPs may have potential clinical utility in fracture healing, spine fusion, reconstructive surgery, oral surgery, and plastic surgery.",
author = "Reddi, {A Hari}",
year = "2003",
month = "7",
day = "7",
doi = "10.1016/B978-012689663-3/50055-7",
language = "English (US)",
isbn = "9780080518794",
pages = "1179--1185",
booktitle = "The Cytokine Handbook",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Bone morphogenetic proteins

AU - Reddi, A Hari

PY - 2003/7/7

Y1 - 2003/7/7

N2 - This chapter describes the role of bone matrix as a repository of growth, and morphogenetic factors, including bone morphogenetic proteins. Demineralized bone matrix is the initial starting biomaterial for isolation, purification and molecular cloning, and expression of bone morphogenetic proteins (BMPs). There are 15 members of the BMP family in humans, and they have wide-ranging actions on tissues beyond bone. The action of BMPs is mediated by receptors for BMPs. The type I and II BMP receptors bind BMPs, and the activated receptors phosphorylate intracellular substrates, called Smads. The term Smad is a fusion of two genes Sma in worms, and a human homolog of a Drosophila gene Mad (mothers against decapentaplegic). BMP receptors phosphorylate Smads 1, 5, and 8 in cytoplasm. Upon phosphorylation they enter the nucleus in partnership with a common partner Smad 4, and turn on the gene expression. The bioavailability of BMPs for receptor binding is influenced by BMP-binding proteins such as noggin and chordin, and interactions with extracellular matrix components, such as type W collagen and heparan sulfate. BMPs may have potential clinical utility in fracture healing, spine fusion, reconstructive surgery, oral surgery, and plastic surgery.

AB - This chapter describes the role of bone matrix as a repository of growth, and morphogenetic factors, including bone morphogenetic proteins. Demineralized bone matrix is the initial starting biomaterial for isolation, purification and molecular cloning, and expression of bone morphogenetic proteins (BMPs). There are 15 members of the BMP family in humans, and they have wide-ranging actions on tissues beyond bone. The action of BMPs is mediated by receptors for BMPs. The type I and II BMP receptors bind BMPs, and the activated receptors phosphorylate intracellular substrates, called Smads. The term Smad is a fusion of two genes Sma in worms, and a human homolog of a Drosophila gene Mad (mothers against decapentaplegic). BMP receptors phosphorylate Smads 1, 5, and 8 in cytoplasm. Upon phosphorylation they enter the nucleus in partnership with a common partner Smad 4, and turn on the gene expression. The bioavailability of BMPs for receptor binding is influenced by BMP-binding proteins such as noggin and chordin, and interactions with extracellular matrix components, such as type W collagen and heparan sulfate. BMPs may have potential clinical utility in fracture healing, spine fusion, reconstructive surgery, oral surgery, and plastic surgery.

UR - http://www.scopus.com/inward/record.url?scp=84884761556&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884761556&partnerID=8YFLogxK

U2 - 10.1016/B978-012689663-3/50055-7

DO - 10.1016/B978-012689663-3/50055-7

M3 - Chapter

SN - 9780080518794

SN - 9780126896633

SP - 1179

EP - 1185

BT - The Cytokine Handbook

PB - Elsevier Inc.

ER -